CTIS.eu › Cities › Germany › Ludwigshafen Am Rhein
Ludwigshafen Am Rhein
Germany
84 total trials
35 recruiting
2023-506906-38-00
5
2024-05-23
Follicular Lymphoma
2022-502966-26-01
5
2023-10-27
Sjögren’s syndrome
2024-512980-29-00
4
2023-08-28
T1-T2N0 esophageal adenocarcinoma including gastroesophageal
junction
2022-501419-15-00
5
2023-08-23
Atrial Fibrillation
2022-501576-25-00
5
2023-07-07
Melanoma
2022-500290-14-01
4
2023-05-11
Colitis ulcerative
2023-509320-17-00
6
2023-03-28
non-radiographic axial spondyloarthritis
2024-513949-37-00
4
2023-03-16
previously untreated aggressive B-cell lymphoma
2024-517132-22-00
5
2023-01-26
active ulcerative colitis
2023-507131-38-00
5
2022-05-16
Neovascular Age-Related Macular Degeneration (nAMD)
2023-507130-24-00
5
2021-10-22
Neovascular age-related macular degeneration (nAMD)
2023-507816-11-00
5
2020-08-17
Macular edema due to central retinal vein occlusion
2022-502478-18-00
4
2019-12-20
Acute Myeloid Leukemia (AML)
2023-503670-21-00
5
2019-08-28
Patients with newly diagnosed AML and intermediate- or adverse-risk ge
2022-502832-37-00
5
2019-03-01
Acute myeloid leukemia
2024-513464-26-00
5
2018-10-18
Multiple Myeloma
2024-514051-15-00
7
2023-07-10
Adult patients with relapsed or refractory IDH1-mutated AML or relapse
2023-504678-39-00
4
2024-03-13
Heart Failure
2022-502788-39-00
4
2023-11-27
acute myocardial infarction
2022-501418-69-00
5
2023-11-21
Acute Coronary Syndrome
2022-502174-16-00
5
2023-09-13
Macular edema secondary to retinal vein occlusion
2022-500746-16-00
4
2023-08-11
Geographic Atrophy
2024-516300-41-00
5
2023-03-07
Multiple Myeloma
2023-504772-21-00
4
2022-11-22
Severely burned patients
Showing 49–72 of 84 trials